Sunday, March 26, 2017 11:52:34 AM
I'm not sure about this, but I believe it's possible that Noreen (the CEO of IMUN) might have been a patient of Dr. Bihari's (I do know that she is a LDN user), and when he passed away, I guess she shared his vision of trying to bring LDN into Africa (first) and IMUN acquired 42 patents from Dr. Bihari after his passing. I could be wrong about that though, I just kind of assumed that's the likely way that Noreen was able to find herself acquiring these patents (by being a patient of his first).
IMUN owns a 55% stake in Cytocom (I believe), and Cytocom is the subsidiary of IMUN that plans to commercialize LDN in the United States in the future. From my understanding, the business plan all along was to get into Africa first, so that LDN becomes established and proven as a successful drug before attempting to get into the United States. It would be easier to get through the FDA in the US after the drug has a proven track record in Africa. As it currently stands, big pharma is against LDN because it is a more effective and CHEAPER drug than its competitors. Big pharma companies will essentially lose a ton of money if LDN is ever FDA approved in the United States, as LDN can replace multiple more expensive drugs for multiple different diseases.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM